The University of Chicago Header Logo

Connection

Theodore Karrison to Pyrrolidinones

Back to Details
This is a "connection" page, showing publications Theodore Karrison has written about Pyrrolidinones.
Theodore Karrison
Connection Strength
0.178
Pyrrolidinones
  1. A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma. Cancer. 2020 05 15; 126(10):2146-2152.
    View in: PubMed
    Score: 0.178
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.